Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent licensing and alliance transactions – mergers and acquisitions are covered in a separate column (see sidebar). Deal Watch is supported by deal intelligence from Strategic Transactions.
[Sidebar#SC124029]








